Plasma Heat Shock Protein 90 Alpha: A Valuable Predictor of Early Chemotherapy Effectiveness in Advanced Non-Small-Cell Lung Cancer

BACKGROUND: Heat shock protein-90 alpha (HSP90α) is more abundant in non-small-cell lung cancer (NSCLC) patients than in control individuals. However, whether it can reflect chemotherapy efficacy remains unknown. This study aimed to investigate the association of HSP90α with chemotherapy in advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Bo, Shen, Juxin, Zhang, Chunyi, Zhou, Guozhong, Yu, Yuefang, Qin, E, Tang, Jixian, Wu, Dongping, Liang, Xiaochao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805245/
https://www.ncbi.nlm.nih.gov/pubmed/33419959
http://dx.doi.org/10.12659/MSM.924778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805245/
https://www.ncbi.nlm.nih.gov/pubmed/33419959
http://dx.doi.org/10.12659/MSM.924778

Ejemplares similares